EA PHARMA CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 2016-04-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.eapharma.co.jp
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2017-10-24
- Lead Sponsor
- EA Pharma Co., Ltd.
- Target Recruit Count
- 39
- Registration Number
- NCT02961556
- Locations
- 🇯🇵
EA Pharma Trial Site #1, Saitama, Japan
🇯🇵EA Pharma Trial Site #2, Shinjuku, Tokyo, Japan
A Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects
Phase 1
Completed
- Conditions
- Japanese Healthy Adult Male Participants
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- EA Pharma Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT02902978
A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease
Phase 1
Completed
- Conditions
- Crohn's Disease
- Interventions
- Drug: E6011 10 mg/kgDrug: E6011 5 mg/kgDrug: E6011 2 mg/kgDrug: E6011 15 mg/kg
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- EA Pharma Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT02039063
© Copyright 2025. All Rights Reserved by MedPath